MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Clinical trials for MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE explained in plain language.
Never miss a new study
Get alerted when new MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE trials appear
Sign up with your email to follow new studies for MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Therapy & diet Team-Up shows promise for fatty liver
Disease control CompletedThis study tested whether adding personalized nutrition advice and psychological support to standard liver doctor visits helps people with fatty liver disease (MASLD) better manage their condition. 286 participants were split into groups receiving different levels of support over…
Matched conditions: MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: NA • Sponsor: University of Campania Luigi Vanvitelli • Aim: Disease control
Last updated Apr 03, 2026 19:55 UTC
-
Gut bugs tested as treatment for common liver condition
Disease control CompletedThis study tested whether taking specific probiotic supplements for 8 weeks could improve liver health in people with fatty liver disease (MASLD). 89 adults with the condition took either one of three probiotic strains or a placebo pill, while also taking a standard liver support…
Matched conditions: MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Chuncheon Sacred Heart Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Could a daily glass of mineral water help your liver?
Disease control CompletedThis study tested whether drinking a specific mineral water daily for 12 months could help people with fatty liver disease. Researchers wanted to see if the water could improve gut health, reduce body-wide inflammation, and lower liver fat. They compared 87 participants who eithe…
Matched conditions: MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: NA • Sponsor: University of Campania Luigi Vanvitelli • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC